1-19 of 19
Manfred Schmitt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P1-13-02: Analysis of the NNBC 3-Europe trial: Addition of docetaxel to anthracycline containing adjuvant chemotherapy in high risk node-negative breast cancer patients.

Christoph Thomssen, Eva-Johanna Kantelhardt, Christoph Meisner, Martina Vetter, Marcus Schmidt, Pierre-Marie Martin, Corinne Veyret, Doris Augustin, Volker Hanf, Daniela Paepke, Fred CGJ Sweep, Manfred Schmitt, Gunter von Minchwitz, Fritz Jaenicke, Nadia Harbeck
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P1-13-02.
https://doi.org/10.1158/0008-5472.SABCS12-P1-13-02
Published: 15 December 2012
View article titled, Abstract P1-13-02: Analysis of the NNBC 3-Europe trial: Addition of docetaxel to anthracycline containing adjuvant chemotherapy in high risk node-negative breast cancer patients.
Journal Articles

Abstract #5459: Y-Box binding protein YB-1 identifies high-risk primary breast cancer patients benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy

Manfred Schmitt, Oleg Gluz, Karin Mengele, Ulrike Nitz, Hans-Dieter Royer, Nadia Harbeck
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5459.
Published: 01 May 2009
View article titled, Abstract #5459: Y-Box binding protein YB-1 identifies high-risk primary breast cancer patients benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy
Journal Articles

PITX2B mRNA expression is associated with poor prognosis in lymph node-negative steroid hormone receptor-positive breast cancer

John W. Martens, Anieta M. Sieuwerts, Marion E. Meijer-Van Gelder, Maxime P. Look, Joan Bolt-De Vries, Inko Nimmrich, Nadia Harbeck, Ralf Lesche, Oliver Hartmann, Henk Portengen, Manfred Schmitt, Sabine Maier, Jan Gm Klijn, John A. Foekens
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 847–848.
Published: 15 April 2006
View article titled, PITX2B mRNA expression is associated with poor prognosis in lymph node-negative steroid hormone receptor-positive breast cancer
Journal Articles

Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer

John W.M. Martens, Inko Nimmrich, Thomas Koenig, Maxime P. Look, Nadia Harbeck, Fabian Model, Antje Kluth, Joan Bolt-de Vries, Anieta M. Sieuwerts, Henk Portengen, Marion E. Meijer-Van Gelder, Christian Piepenbrock, Alexander Olek, Heinz Höfler, Marion Kiechle, Jan G.M. Klijn, Manfred Schmitt, Sabine Maier, John A. Foekens
Journal: Cancer Research
Cancer Res (2005) 65 (10): 4101–4117.
https://doi.org/10.1158/0008-5472.CAN-05-0064
Published: 15 May 2005
View article titled, Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer
Open the PDF for Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Analysis of the differential expression of proteolytic factors uPA, PAI-1, and seven tissue kallikreins (hk5,6,7,8,10,11,13) between primary ovarian carcinoma tissues and corresponding omentum metastases

Julia Dorn, Nadia Harbeck, Ronald Kates, Andreas Scorilas, C. Linda Grass, Antoninus Soosaipillai, Eleftherios P. Diamandis, Marion Kiechle, Barbara Schmalfeldt, Manfred Schmitt
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 698.
Published: 01 May 2005
View article titled, Analysis of the differential expression of proteolytic factors uPA, PAI-1, and seven tissue kallikreins (hk5,6,7,8,10,11,13) between primary ovarian carcinoma tissues and corresponding omentum metastases
Journal Articles

DNA-hypermethylation of PITX2 and risk of breast cancer recurrence in lymph node-negative hormone receptor-positive breast cancer patients

John W. M. Martens, Sabine Maier, Ina Schwope, Thomas Koenig, Oliver Hartmann, Antje Kluth, Maxime P. Look, Nadia Harbeck, Joan Bolt-De Vries, Anieta M. Sieuwerts, Henk Portengen, Marion E. Meijer-Van Gelder, Manfred Schmitt, Jan G. M. Klijn, John A. Foekens, Inko Nimmrich
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 650.
Published: 01 May 2005
View article titled, DNA-hypermethylation of PITX2 and risk of breast cancer recurrence in lymph node-negative hormone receptor-positive breast cancer patients
Journal Articles

Urokinase-Type Plasminogen Activator System in Breast Cancer: Association with Tamoxifen Therapy in Recurrent Disease

Marion E. Meijer-van Gelder, Maxime P. Look, Harry A. Peters, Manfred Schmitt, Nils Brünner, Nadia Harbeck, Jan G. M. Klijn, John A. Foekens
Journal: Cancer Research
Cancer Res (2004) 64 (13): 4563–4568.
https://doi.org/10.1158/0008-5472.CAN-03-3848
Published: 01 July 2004
View article titled, Urokinase-Type Plasminogen Activator System in Breast Cancer: <subtitle>Association with Tamoxifen Therapy in Recurrent Disease</subtitle>
Open the PDF for Urokinase-Type Plasminogen Activator System in Breast Cancer: <subtitle>Association with Tamoxifen Therapy in Recurrent Disease</subtitle> in another window
Journal Articles

Human kallikrein 8 protein (hK8) in ovarian cancer cytosols: A new marker of favorable prognosis

Carla A. Borgono, Tadaaki Kishi, Andreas Scorilas, Nadia Harbeck, Julia Dorn, Barbara Schmalfeldt, Manfred Schmitt, Eleftherios P. Diamandis
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1025.
Published: 01 April 2004
View article titled, Human kallikrein 8 protein (hK8) in ovarian cancer cytosols: A new marker of favorable prognosis
Journal Articles

Stereo selective anti-tumor and anti-metastatic effects of the serine protease inhibitors: WX-UK1 and D-WX-UK1 administered to brown Norwegian rats bearing syngeneic BN-472 mammary tumor.

Buddy Setyono-Han, Wolfgang A. Schmalix, Anieta M. Sieuwerts, Bernd Muehlenweg, Mieke Timmermans, Viktor Magdolen, Maxime P. Look, Manfred Schmitt, Jan G. Klijn, John A. Foekens
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 472.
Published: 01 April 2004
View article titled, Stereo selective anti-tumor and anti-metastatic effects of the serine protease inhibitors: WX-UK1 and D-WX-UK1 administered to brown Norwegian rats bearing syngeneic BN-472 mammary tumor.
Journal Articles

Human Kallikrein 5: A Potential Novel Serum Biomarker for Breast and Ovarian Cancer

George M. Yousef, Mary-Ellen Polymeris, Linda Grass, Antoninus Soosaipillai, Pak-Cheung Chan, Andreas Scorilas, Carla Borgoño, Nadia Harbeck, Barbara Schmalfeldt, Julia Dorn, Manfred Schmitt, Eleftherios P. Diamandis
Journal: Cancer Research
Cancer Res (2003) 63 (14): 3958–3965.
Published: 21 July 2003
View article titled, Human Kallikrein 5: <subtitle>A Potential Novel Serum Biomarker for Breast and Ovarian Cancer</subtitle>
Open the PDF for Human Kallikrein 5: <subtitle>A Potential Novel Serum Biomarker for Breast and Ovarian Cancer</subtitle> in another window
Journal Articles

Human Kallikrein 8, a Novel Biomarker for Ovarian Carcinoma

Tadaaki Kishi, Linda Grass, Antoninus Soosaipillai, Andreas Scorilas, Nadia Harbeck, Barbara Schmalfeldt, Julia Dorn, Michal Mysliwiec, Manfred Schmitt, Eleftherios P. Diamandis
Journal: Cancer Research
Cancer Res (2003) 63 (11): 2771–2774.
Published: 01 June 2003
View article titled, Human Kallikrein 8, a Novel Biomarker for Ovarian Carcinoma
Open the PDF for Human Kallikrein 8, a Novel Biomarker for Ovarian Carcinoma in another window
Journal Articles

Enhanced Benefit from Adjuvant Chemotherapy in Breast Cancer Patients Classified High-Risk according to Urokinase-type Plasminogen Activator (uPA) and Plasminogen Activator Inhibitor Type 1 ( n = 3424)

Nadia Harbeck, Ronald E. Kates, Maxime P. Look, Marion E. Meijer-van Gelder, Jan G. M. Klijn, Achim Krüger, Marion Kiechle, Fritz Jänicke, Manfred Schmitt, John A. Foekens
Journal: Cancer Research
Cancer Res (2002) 62 (16): 4617–4622.
Published: 15 August 2002
View article titled, Enhanced Benefit from Adjuvant Chemotherapy in Breast Cancer Patients Classified High-Risk according to Urokinase-type Plasminogen Activator (uPA) and Plasminogen Activator Inhibitor Type 1 ( <em>n</em> = 3424)
Open the PDF for Enhanced Benefit from Adjuvant Chemotherapy in Breast Cancer Patients Classified High-Risk according to Urokinase-type Plasminogen Activator (uPA) and Plasminogen Activator Inhibitor Type 1 ( <em>n</em> = 3424) in another window
Journal Articles

Cancer Progression and Tumor Cell Motility Are Associated with the FGFR4 Arg388 Allele

Johannes Bange, Dieter Prechtl, Yuri Cheburkin, Katja Specht, Nadia Harbeck, Manfred Schmitt, Tatjana Knyazeva, Susanne Müller, Silvia Gärtner, Irmi Sures, Hongyang Wang, Evgeny Imyanitov, Hans-Ulrich Häring, Pjotr Knayzev, Stefano Iacobelli, Heinz Höfler, Axel Ullrich
Journal: Cancer Research
Cancer Res (2002) 62 (3): 840–847.
Published: 01 February 2002
View article titled, Cancer Progression and Tumor Cell Motility Are Associated with the FGFR4 Arg<sup>388</sup> Allele
Open the PDF for Cancer Progression and Tumor Cell Motility Are Associated with the FGFR4 Arg<sup>388</sup> Allele in another window
Journal Articles

Hydroxamate-Type Matrix Metalloproteinase Inhibitor Batimastat Promotes Liver Metastasis

Achim Krüger, Rita Soeltl, Igor Sopov, Charlotte Kopitz, Matthias Arlt, Viktor Magdolen, Nadia Harbeck, Bernd Gänsbacher, Manfred Schmitt
Journal: Cancer Research
Cancer Res (2001) 61 (4): 1272–1275.
Published: 02 February 2001
View article titled, Hydroxamate-Type Matrix Metalloproteinase Inhibitor Batimastat Promotes Liver Metastasis
Open the PDF for Hydroxamate-Type Matrix Metalloproteinase Inhibitor Batimastat Promotes Liver Metastasis in another window
Journal Articles

The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients

John A. Foekens, Harry A. Peters, Maxime P. Look, Henk Portengen, Manfred Schmitt, Michael D. Kramer, Nils Brünner, Fritz Jänicke, Marion E. Meijer-van Gelder, Sonja C. Henzen-Logmans, Wim L. J. van Putten, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (2000) 60 (3): 636–643.
Published: 01 February 2000
View article titled, The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients
Open the PDF for The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients in another window
Journal Articles

Prognostic Impact of Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1 in Completely Resected Gastric Cancer

Hjalmar Nekarda, Manfred Schmitt, Kurt Ulm, Andrea Wenninger, Holger Vogelsang, Karen Becker, Jürgen D. Roder, Ulrich Fink, Jörg R. Siewert
Journal: Cancer Research
Cancer Res (1994) 54 (11): 2900–2907.
Published: 01 June 1994
View article titled, Prognostic Impact of Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1 in Completely Resected Gastric Cancer
Open the PDF for Prognostic Impact of Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1 in Completely Resected Gastric Cancer in another window
Journal Articles

Both the Cytosols and Detergent Extracts of Breast Cancer Tissues Are Suited to Evaluate the Prognostic Impact of the Urokinase-Type Plasminogen Activator and Its Inhibitor, Plasminogen Activator Inhibitor Type 1

Fritz Jänicke, Lothar Pache, Manfred Schmitt, Kurt Ulm, Christoph Thomssen, Anita Prechtl, Henner Graeff
Journal: Cancer Research
Cancer Res (1994) 54 (10): 2527–2530.
Published: 01 May 1994
View article titled, Both the Cytosols and Detergent Extracts of Breast Cancer Tissues Are Suited to Evaluate the Prognostic Impact of the Urokinase-Type Plasminogen Activator and Its Inhibitor, Plasminogen Activator Inhibitor Type 1
Open the PDF for Both the Cytosols and Detergent Extracts of Breast Cancer Tissues Are Suited to Evaluate the Prognostic Impact of the Urokinase-Type Plasminogen Activator and Its Inhibitor, Plasminogen Activator Inhibitor Type 1 in another window
Journal Articles

Prognostic Value of Urokinase-type Plasminogen Activator in 671 Primary Breast Cancer Patients

John A. Foekens, Manfred Schmitt, Wim L. J. van Putten, Harry A. Peters, Marijke Bontenbal, Fritz Jänicke, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (1992) 52 (21): 6101–6105.
Published: 01 November 1992
View article titled, Prognostic Value of Urokinase-type Plasminogen Activator in 671 Primary Breast Cancer Patients
Open the PDF for Prognostic Value of Urokinase-type Plasminogen Activator in 671 Primary Breast Cancer Patients in another window
Journal Articles

Fibrin-Fibronectin Compounds in Human Ovarian Tumor Ascites and Their Possible Relation to the Tumor Stroma

Olaf Wilhelm, Reimar Hafter, Eva Coppenrath, MaryAnn Pflanz, Manfred Schmitt, Rudolf Babic, Reinhold Linke, Wolfgang Gössner, Henner Graeff
Journal: Cancer Research
Cancer Res (1988) 48 (12): 3507–3514.
Published: 01 June 1988
View article titled, Fibrin-Fibronectin Compounds in Human Ovarian Tumor Ascites and Their Possible Relation to the Tumor Stroma
Open the PDF for Fibrin-Fibronectin Compounds in Human Ovarian Tumor Ascites and Their Possible Relation to the Tumor Stroma in another window